secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-03-25T23:59:59+00:00
Accession:  0001641172-25-000595
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals enters consulting deal with Bowery; $260K fee due after Nasdaq compliance regained
--------------------------------------------------------------------------------

- Six-month consulting agreement with Bowery Consulting Group effective March 21, 2025.
- Services include research, due diligence, partnership evaluation, and capital raising strategy.
- Total fee of $260,000, payable only after Shuttle regains full compliance with Nasdaq Listing Rules.
- Agreement aims to support reaching milestones and attract investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225000595/0001641172-25-000595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000164117225000595/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-000595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer